A potential role of caspase recruitment domain family member 9 (Card9) in transverse aortic constriction-induced cardiac dysfunction, fibrosis, and hypertrophy
- PMID: 32647279
- DOI: 10.1038/s41440-020-0507-0
A potential role of caspase recruitment domain family member 9 (Card9) in transverse aortic constriction-induced cardiac dysfunction, fibrosis, and hypertrophy
Abstract
Macrophage- and monocyte-derived cytokines are elevated in the myocardium of pressure-overloaded hearts, where they play critical roles in pathological remodeling. Caspase recruitment domain family member 9 (CARD9) regulates macrophage cytokine secretion, but its role in a transverse aortic constriction (TAC) model of pressure overload has not been evaluated. To investigate whether CARD9 may serve as a valuable therapeutic target, wild-type (WT) and CARD9-knockout mice were subjected to 3 months of TAC, and then cardiac function, hypertrophy, and fibrosis were analyzed. The expression of protein markers of myocardial autophagy and nuclear factor kappa B signaling was also investigated. At 1 month after TAC, cardiomyocyte contractile dynamics were measured in a separate cohort to further assess contractility and diastolic function. In WT but not CARD9-/- mice, TAC resulted in severe cardiomyocyte contractile dysfunction at 1 month and functional decrements in fractional shortening at 3 months in vivo. Furthermore, CARD9-/- mice did not develop cardiac fibrosis or hypertrophy. CARD9-/- mice also had decreased protein expression of inhibitor of κB kinase-α/β, decreased phosphorylation of p65, and increased expression of protein markers of autophagy. These findings suggest that CARD9 plays a role in pathological remodeling and cardiac dysfunction in mouse hearts subjected to TAC and should be investigated further.
Keywords: CARD9; Hypertension; Inflammation; Pressure overload; TAC.
Comment in
-
CARD9: key player or bystander in cardiac remodeling under hypertension?Hypertens Res. 2020 Dec;43(12):1454-1456. doi: 10.1038/s41440-020-00542-9. Epub 2020 Sep 2. Hypertens Res. 2020. PMID: 32873900 No abstract available.
References
-
- The World Health Organization. Health statistics and information systenms: disease burden and mortality estimates. Geneva: World Health Organization; 2020.
-
- GBD 2015 Risk Factors Collaborators Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–724. https://doi.org/10.1016/S0140-6736(16)31679-8 . - DOI
-
- World Health Organization. Health statistics and information systems: disease burden and mortality estimates. Geneva: World Health Organization; 2018.
-
- Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149–54. https://doi.org/10.1038/sj.jhh.1001785 . - DOI - PubMed
-
- Dorffel Y, Latsch C, Stuhlmuller B, Schreiber S, Scholze S, Burmester GR, et al. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension. 1999;34:113–7. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical